FDA Finalizes Mad Cow Disease Rules

Agribusiness
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
Data pix.
A rule finalizing interim plans for Bovine Spongiform Encephalopathy (BSE), also known as mad cow disease, was released by the Food and Drug Administration (FDA).
The rules were made to reduce risks of the disease in human food.
The FDA says the final rule provides definitions for prohibited cattle materials and and how they are used in food, supplements, and cosmetics. Including: Specified risk materials like brain, skull, eyes, and spinal cord of cattle 30 months and older; the small intestine; material from nonambulatory disabled cattle: and material from cattle not inspected and passed.
The rule also clarifies that milk, hide, and tallow or their products are not subject to restrictions. Also, as long as gelatin is manufactured using customary industry processes, it is not considered a prohibited cattle material.
The FDA says U.S. has measures in place preventing introduction and spread of BSE and risk of human exposure is negligible.

Popular

Latest News

More News